Altimmune (ALT) Amortizatization of Intangibles (2016 - 2026)
Altimmune (ALT) reported Amortizatization of Intangibles of $870000.0 for Q1 2026, up 26.82% year-over-year from $686000.0 in Q1 2025, and down 4.5% quarter-over-quarter from $911000.0 in Q4 2025.
Altimmune (ALT) Amortizatization of Intangibles (2016 - 2026) Analysis & Trends
Altimmune (ALT) has 9 years of Amortizatization of Intangibles data on file, last reported at $870000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $870000.0, up 26.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (down 32.23% YoY), and the FY2025 annual result was $2.2 million, down 42.23% from the prior year.
- Amortizatization of Intangibles fell to $870000.0 in Q1 2026 per ALT's latest filing, from $911000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.1 million in Q2 2024 and troughed at $196000.0 in Q3 2025.
- A 4-year average of $724230.8 and a median of $695000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles jumped 104.37% in 2024, then plunged 79.98% in 2025.
- A 4-year view of Amortizatization of Intangibles shows it stood at $695000.0 in 2023, then advanced by 17.84% to $819000.0 in 2024, then climbed by 11.23% to $911000.0 in 2025, then declined by 4.5% to $870000.0 in 2026.
- Business Quant data shows ALT's Amortizatization of Intangibles at $870000.0 in Q1 2026, $911000.0 in Q4 2025, and $196000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | 870,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 870,000.00 |
| Mar 31, 2026 | 870,000.00 |
| Dec 31, 2025 | 911,000.00 |
| Dec 31, 2025 | 911,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Jun 30, 2025 | 431,000.00 |
| Jun 30, 2025 | 431,000.00 |
| Mar 31, 2025 | 686,000.00 |
| Mar 31, 2025 | 686,000.00 |
| Dec 31, 2024 | 819,000.00 |
| Dec 31, 2024 | 819,000.00 |
| Sep 30, 2024 | 979,000.00 |
| Sep 30, 2024 | 979,000.00 |
| Jun 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 983,000.00 |
| Mar 31, 2024 | 983,000.00 |
| Dec 31, 2023 | 695,000.00 |
| Dec 31, 2023 | 695,000.00 |